Anti-Microbial Peptides Market 2024 | Insights, Trends, Demand & Competitors Analysis (1)

1
Report Code HC1001
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
1-646-568-7747
1-437-886-1181
44-203-318-6627
91-120-473-0422, 91-844-785-9968
sales_at_goldsteinresearch.com
2
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
Anti-Microbial Peptides Market Outlook In
2013, as per US Centers for Disease Control and
Prevention, over 2 million health related
problems were reported in the U.S., out of which
23,000 people died due to drug-resistant
microbes. In 2012, in the U.S., more than 450,000
new cases were registered against multidrug
resistant tuberculosis. Rising number drug
resistant cases across the world is creating need
for the development of new antibiotics to fight
against simple infectious diseases. Peptides
such as Oxytocin, Cyclosporin, Salmon Calcitonin,
Integrillin and Zoladex are widely accepted and
are discovering new ways for peptide therapeutics
market across the globe. As anti-microbial
peptides market is in its embryonic stage and RD
is also facing challenges in developing new
antimicrobials peptides. To prioritize the things
U.S. and European Union government have taken
initiatives and launched a Transatlantic Task
Force and the Infectious Diseases Society of
America in 2012 for the development of novel
antimicrobial peptides by the end of 2020.
Moreover, in Asia-Pacific region, Australian and
New Zealand biotechnology organizations are
funding together in manufacturing of new
peptides. In 2007, Mimotopes Pty Ltd. and
GlycoSyn were funded with USD 519.85 million to
manufacture new peptides and specialized small
molecules under the conditions of Good
Manufacturing Practices (GMP). Leading market
players are collaborating to perform research on
anti-microbial peptides. For instance, Symcel and
Colzyx have partnered together to test
antimicrobial peptides and their ability to
restrict the bacterial growth. Recently
established companies such as Nuritas are
combining artificial intelligence and DNA
analysis to find out peptides which can provide
health benefits. Moreover, PFIZER acquired COVX
to expand its bio-therapeutics investments for
the identification of new peptide products.
3
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis

• Market Segmentation
• Based on Peptides
• By Peptides Type
• Plant Anti-Microbial Peptides
• Bacterial Anti-Microbial Peptides
• Animal Anti-Microbial Peptides
• Insects Anti-Microbial Peptides
• By Products Type
• Natural Anti-Microbial Peptides
• Artificial Anti-Microbial Peptides
• By Application
• Personal Care and Cosmetics Industry
• Healthcare Pharmaceuticals Industry
• Biotechnology Industry
• Send Us Sample Request _at_ https//www.goldsteinrese
  arch.com/request-sample/middle-east-africa-connect
  ed-car-market-outlook-2024-opportunity-assessment-
  and-demand-analysis-market-forecast-2016-2024

4
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis

• Based on Geography
• North America (U.S. Canada) Market Size (USD
  Billion), Growth Analysis () and Adoption Rate
  ()
• Latin America (Brazil, Mexico Rest of Latin
  America)         Market Size (USD Billion),
  Growth Analysis () and Adoption Rate ()
• Europe (The U.K., Germany, France, Italy, Spain,
  Poland, Sweden RoE) Market Size (USD Billion),
  Growth Analysis () and Adoption Rate ()
• Asia-Pacific (China, India, Japan, Singapore,
  South Korea, Australia, New Zealand, Rest of
  Asia) Market Size (USD Billion), Growth Analysis
  () and Adoption Rate ()
• Middle East Africa (GCC, South Africa, North
  Africa, RoMEA) Market Size (USD Billion), Growth
  Analysis () and Adoption Rate ()
• Rest of World Market Size (USD Billion), Growth
  Analysis () and Adoption Rate ()
• Request for TOC _at_https//www.goldsteinresearch.com
  /toc-request/middle-east-africa-connected-car-mark
  et-outlook-2024-opportunity-assessment-and-demand-
  analysis-market-forecast-2016-2024

5
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
Market Size and Forecast (2016-2024) Peptide
therapeutics market holds 2-3 of share in global
pharmaceuticals market. The global antimicrobial
peptide market is highly fragmented and valued
USD 1.06 billion in 2015. The global market for
antimicrobial peptide is anticipated to grow at a
CAGR of 7.5 over the forecast period. Europe
and North America are the leading regions for
global anti-microbial peptide market due to large
investment in RD. Collectively Europe and North
America held approximately 80 share of global
antimicrobial peptides market in 2016. North
America anti-microbial peptides market valued USD
0.44 billion in 2016. Presence of leading players
in the region and huge of RD spending is
supporting the growth of anti-microbial peptides
market in North America region.
6
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
Global Anti-Microbial Peptides Market outlook
2024 contains detailed overview of the global
anti-microbial peptides market in terms of market
segmentation by peptides type, by product and by
application. Further, for the in-depth analysis,
Antimicrobial peptides market research report
encompasses the industry growth drivers, market
challenges, risk analysis, market attractiveness,
BPS (Base Point Scale) analysis, Porters five
force model and SWOT analysis. Global
anti-microbial peptides market report also
provides competitive outlook of some of the major
players of global anti-microbial peptides market
which includes profiling of companies such as
AnaSpec Inc., Chinese Peptides, Novozymes, Lonza,
Ipsen, Bachem Holding AG, Nuritas, Dermagen,
Phoenix Biotech, AMP Biotech, Shanghai Abbiochem
Company, Ramamoorthy Group, Lytix Biopharma AS,
Ai2 Ltd and C3 Jian Therapeutics. The company
profiles include business strategy, geographical
revenue distribution, major information of the
companies which encompasses business outlook,
products, services and industries catered,
financial analysis of the company and recent
developments. Overall, the report represents
comprehensive synopsis on the global
anti-microbial peptides market trends that will
help industry consultants, equipment
manufacturers, existing players searching for
expansion opportunities, new players searching
possibilities and other stakeholders to align
their market centric strategies according to the
ongoing and expected trends in the future.
7
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis

• Scope Background
•  Market Synopsis
•  
• Market Segmentation
•  
• The Global Anti microbial peptides Market
  segmentation as follows
• By Peptides Type (Market Size, Demand Analysis
  and Growth Analysis)
• By Products (Market Size, Demand Analysis and
  Growth Analysis)
• By Application (Market Size, Demand Analysis and
  Growth Analysis)
•  
• By Country
• North America (U.S., Canada) Market Size, Growth
  Analysis and Opportunity Analysis
• Latin America (Argentina, Mexico, Brazil and Rest
  of Latin America) Market Size, Growth Analysis
  and Opportunity Analysis
• Europe (Germany, Italy, Spain, France, The U.K.,
  Netherlands, Sweden, Hungary, Russia, Poland,
  Rest of Europe) Market Size, Growth Analysis and
  Opportunity Analysis
• Asia-Pacific (China, India, Singapore, Japan,
  Hong-Kong, Australia, New Zealand, South Korea
  and Rest of Asia Pacific) Market Size, Growth
  Analysis and Opportunity Analysis
• Middle East and North Africa (MENA) Market Size,
  Growth Analysis and Opportunity Analysis
• Rest of World  Market Size, Growth Analysis and
  Opportunity Analysis

8
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis

• Market Dynamics Growth Drivers, Restraints and
  Opportunities
• Risk Factors
• Regional Variations
• Recent Trends and Developments
• Key Market Players
• Synopsis
• Business Strategy
• Product Portfolio
• SWOT Analysis
• Porters Five Force Model
• Market Landscape Competition and Beyond
• Market outlook for business players and entry
  level players to ascertain their business in
  dynamic ecosystem
• Expert Analysis
• Concluding Remarks

9
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
About Goldstein Research Based in U.S., Goldstein
Research is a young business consulting and
market research firm with vast reach across
America, Asia and parts of Europe and the Middle
East. In the next five years, we strive to
expand our reach to 50 nations spanning across
Europe, Asia and parts of the Middle East and
Africa. We strive to realize a strong brand
presence globally through our quality research
and forecasting solutions. With 30 domain
experts and 50 employees working day and night
to crunch numbers and bring out the best and
detailed market reports and forecasts, we strive
to enable you to foresee upcoming market
challenges and develop a robust business model
and strategies, which would add to your
profitability and market visibility as a
brand. Our mission is simple to develop
insightful business solutions, help our clients
make powerful future decisions to keep them well
ahead of the game which is the market, and leave
a mark across businesses and communities through
our well-defined ideas and clear cut forecasts.
Our mission is simple to develop insightful
business solutions, help our clients make
powerful future decisions to keep them well ahead
of the game which is the market, and leave a mark
across businesses and communities through our
well-defined ideas and clear cut forecasts.
10
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
For more information Contact Us
11
Anti-Microbial Peptides Market 2024 Insights,
Trends, Demand Competitors Analysis
Thank you
Thank you